Latest in Biotech’s
Sort by
10 items
-
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...Business - MarketWatch - 13 hours ago -
Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin
Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin.Business - MarketWatch - November 7 -
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and ...Business - MarketWatch - November 7 -
Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforce
More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.Business - MarketWatch - October 17 -
Small-cap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatment
The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...Business - MarketWatch - October 16 -
To top China in biotech, support US seedbeds of innovation
Congress's ambition to break our dependence on this China-derived supply chain must be paired with an equal zeal for investing in domestic capabilities.Politics - The Hill - October 16 -
Biotech stock tumbles after unexplained 1,446% gain
Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise.Business - MarketWatch - October 16